Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres

View source ↗

Summary

A completed retrospective observational chart review in UK severe asthma centers analyzing real-world use of tezepelumab, including patient characteristics, tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezspire (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Status: COMPLETED